Market Tracker

04/23 8:27am ET

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

145.35
Data as of Apr 22
 +7.02 / +5.07%
Today’s Change
53.29
Today|||52-Week Range
176.60
+14.85%
Year-to-Date

Today’s Trading

Previous close138.33
Today’s open141.65
Day’s range-- - --
Volume1,228,148
Average volume (3 months)1,300,227
Market cap$7.9B
Dividend yield--
Data as of 04/22/2014

Growth & Valuation

Earnings growth (last year)-16.60%
Earnings growth (this year)+29.40%
Earnings growth (next 5 years)+20.65%
Revenue growth (last year)+48.88%
P/E ratio27.0
Price/Sales8.46
Price/Book6.08

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+1.87+3.94%
RDYDr.Reddy's Laborator...+0.36+0.85%
HSPHospira Inc+0.54+1.25%
ENDPEndo International P...+1.67+2.79%
Data as of 04/22/2014

Financials

Next reporting dateMay 6, 2014
EPS forecast (this quarter)$1.91
Annual revenue (last year)$872.4M
Annual profit (last year)$216.3M
Net profit margin24.79%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Secretary &
Executive VP-Technical Operations
Fintan Keegan
Corporate headquarters
Dublin, Dublin

Forecasts